User profiles for S. Gaseitsiwe

Simani Gaseitsiwe

Research Associate, Harvard School of Public Health and Laboratory Director Botswana …
Verified email at bhp.org.bw
Cited by 5253

[HTML][HTML] Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa

…, A Glass, DP Martin, A Rambaut, S Gaseitsiwe… - Nature, 2022 - nature.com
The SARS-CoV-2 epidemic in southern Africa has been characterized by three distinct waves.
The first was associated with a mix of SARS-CoV-2 lineages, while the second and third …

[HTML][HTML] Emergence of SARS-CoV-2 omicron lineages BA. 4 and BA. 5 in South Africa

…, A Rambaut, O Laguda-Akingba, S Gaseitsiwe… - Nature medicine, 2022 - nature.com
Three lineages (BA.1, BA.2 and BA.3) of the severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) Omicron variant of concern predominantly drove South Africa’s fourth …

[HTML][HTML] An early warning system for emerging SARS-CoV-2 variants

…, J Druce, P Effler, I El Masry, A Faye, S Gaseitsiwe… - Nature medicine, 2022 - nature.com
… Fourth, too much of the world’s vulnerable population remains unvaccinated at present,
and current vaccines are suboptimal in preventing transmission. Given these challenges in …

[HTML][HTML] Mycobacterium tuberculosis Next-Generation Whole Genome Sequencing: Opportunities and Challenges

…, L Mupfumi, S Moyo, S Gaseitsiwe… - Tuberculosis research …, 2018 - hindawi.com
Mycobacterium tuberculosis drug resistance is a threat to global tuberculosis (TB) control.
Comprehensive and timely drug susceptibility determination is critical to inform appropriate …

Continued emergence and evolution of Omicron in South Africa: New BA. 4 and BA. 5 lineages

…, A Glass, DP Martin, A Rambaut, S Gaseitsiwe… - MedRxiv, 2022 - medrxiv.org
… South Africa’s fourth COVID-19 wave was driven … be identified by the proxy marker of S-gene
target failure with the TaqPath… on the S-genes of viruses in either the BA.4 or BA.5 lineages. …

[HTML][HTML] Universal testing, expanded treatment, and incidence of HIV infection in Botswana

…, C Sexton, E Raizes, S Gaseitsiwe… - … England Journal of …, 2019 - Mass Medical Soc
Background The feasibility of reducing the population-level incidence of human immunodeficiency
virus (HIV) infection by increasing community coverage of antiretroviral therapy (ART) …

The reverse transcriptase 67N 70R 215Y genotype is the predominant TAM pathway associated with virologic failure among HIV type 1C-infected adults treated with …

…, S Gaseitsiwe, A Thomas, S Moyo… - AIDS research and …, 2007 - liebertpub.com
… manufacturer’s instructions. A volume of 0.5 ml of plasma was used for HIV-1 RNA isolation
by high-speed centrifugation followed by lysis of virus particles with a chaotropic agent, and …

[HTML][HTML] African-led health research and capacity building-is it working?

…, E Hunter, W Kilembe, E Karita, S Gaseitsiwe… - BMC Public Health, 2020 - Springer
… As we look towards SANTHE’s future, and a potential expansion to 3 new partner sites (in
Cameroon, Zimbabwe and Uganda), we have assessed the tools we use, with help from …

Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?

…, BT Foley, S Gaolekwe, N Rybak, S Gaseitsiwe… - Journal of …, 2002 - Am Soc Microbiol
An evolving dominance of human immunodeficiency virus type 1 subtype C (HIV-1C) in the
AIDS epidemic has been associated with a high prevalence of HIV-1C infection in the …

H3ABioNet, a sustainable pan-African bioinformatics network for human heredity and health in Africa

…, S Gaseitsiwe, H Ghazal, S Hazelhurst… - Genome …, 2016 - genome.cshlp.org
The application of genomics technologies to medicine and biomedical research is
increasing in popularity, made possible by new high-throughput genotyping and sequencing …